Igevia

What Igevia does

Igevia, operating under HealthCare Commerce GmbH, is a Vienna-based digital health diagnostics company founded in 2018 by Dominik Flener (CEO) and Gerhard Feilmayr. The company's core proposition is at-home medical testing, anchored by an allergy test built on the MADx ALEX 3 multiplex IgE chip — licensed exclusively to Igevia for "out-of-home" use — that screens 300 allergens from a single sample. The portfolio has expanded to include a DNA-based metabolism test covering 23 SNPs across 19 genes and a stool-DNA gut-flora test, positioning the company as a multi-vertical at-home diagnostics provider rather than a single-product allergy brand.

The business model is a dual-channel setup. Direct-to-consumer e-commerce is the primary channel, retail-priced at €189 per test with a €171 rate for PKA (Austrian pharmacists' association) members; online sales rose from 60% to 80% of volume during the COVID period. A parallel B2B channel serves healthcare professionals through a quote-based pricing structure, complemented by a German laboratory partnership for cross-border sample processing. Commercial footprint spans Austria, Germany, the UK, and Ireland, with Benelux and Scandinavian markets identified as next-stage expansion targets. The company operated as bootstrapped and self-financed through 2020, when it surfaced investor interest via the Austrian TV program "2 Minuten 2 Millionen." Headcount stands at approximately four employees and customer count exceeded 5,000 by March 2020, though no recurring-revenue economics, retention metrics, or annual revenue figures have been disclosed.

Name

Igevia

Legal name

HealthCare Commerce GmbH

Website

https://igevia.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Igevia is a Vienna-based digital health company founded in 2018 that sells at-home allergy, metabolism, and gut-flora diagnostic tests direct-to-consumers and via healthcare professionals across Austria, Germany, the UK, and Ireland.

Ownership category

akta.pro rank

Product category

Home Diagnostic Testing Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAKAAAL

Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT)

Healthcare & Life Sciences/Specialist Medical Practice/Allergy & Immunology

Keywords

• At-home allergy testing
• Multiplex IgE diagnostics
• Home blood collection kits
• Gut microbiome testing
• DNA metabolism analysis

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Direct Test Kit Sales (B2C): Igevia sells allergy test kits directly to private consumers in Austria via its own e-commerce website. Consumers order online, receive a test kit by post, collect a blood sample at home, mail it to the partner laboratory, and retrieve results via a secure online portal. The test kit (189 EUR) includes the blood collection supplies, pre-paid return shipping, and the analysis report.
2. B2B / HCP Bulk Sales: Igevia sells test kits in bulk to healthcare professionals (doctor practices, pharmacies, occupational health physicians) at negotiated/exclusive pricing. HCPs can also order supplementary materials such as patient brochures, info posters, and pollen calendars. This channel is the primary go-to-market motion alongside e-commerce.
3. Additional Diagnostic Tests: Beyond the core allergy test, Igevia has launched a metabolism test (DNA-based SNP analysis for 23 polymorphisms in 19 genes related to metabolism type, nutrition and sports recommendations) and a gut flora test (stool sample DNA analysis). These represent additional one-time product revenue streams.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Core offering

Igevia sells at-home diagnostic test kits that allow customers to collect a small blood, stool, or buccal sample at home, mail it to a partner laboratory, and receive a comprehensive IgE-based allergy report, a DNA-based metabolism report, or a gut microbiome report through a secure online portal. The core product is the allergy test powered by the ALEX 3 (Allergy Xplorer 3) multiplex diagnostic chip from Macro Array Diagnostics, analyzing 300 allergens plus total IgE and cross-reactivity in a single test.

Product overview

Igevia is a digital health diagnostics platform offering home-based medical tests for allergies, metabolism, and gut health. The core product is the allergy test using ALEX 3 multiplex IgE technology analyzing 300 allergens, complemented by a DNA-based metabolism test (23 SNPs across 19 genes) and a gut microbiome analysis test. All tests use home-collected samples mailed to partner laboratories, with results delivered through a secure online portal featuring detailed reports and actionable recommendations. The company operates a dual-channel model: direct-to-consumer sales in Austria and a partner program for healthcare professionals (doctors, pharmacies, dietitians) across Austria and Germany.

Differentiator

Problem solved

Functional benefit

Brands

• igevia-Allergietest: Home-based blood test for 300 allergens using ALEX 3 multiplex IgE diagnostics.
• igevia-Darmfloratest
• igevia-Stoffwechseltest

Products and services

• Igevia Allergy Test A home-based blood test kit that analyzes IgE antibody responses against 300 specific allergens using the ALEX 3 multiplex diagnostic chip. Customers perform a finger-prick blood collection at home, mail the sample to a partner laboratory, and receive a 12-page report with allergen-specific IgE values, total IgE, cross-reaction analysis, and actionable recommendations through a secure online portal within approximately 10-14 days. Priced at EUR 189 per kit for private consumers.
• Igevia Metabolism Test A DNA-based home test using a buccal swab to analyze 23 single nucleotide polymorphisms (SNPs) in 19 genes to determine an individual's metabolic type. Delivers personalized nutrition and sports recommendations based on genetic predisposition for carbohydrate, protein, and fat metabolism.
• Igevia Gut Flora Test A home stool sample test that analyzes gut microbiome DNA to assess gut health status and disease risk. Provides personalized nutrition tips and supplement recommendations based on bacterial composition and diversity patterns.

Quantifiable outcome

• Reduces time-to-diagnosis from average 9 years (current standard in Austria) to approximately 10–14 days
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature5 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Österreichische Gesellschaft vom Goldenen Kreuze (ÖGGK)minorGTM or Marketing Partner · 1 January 2019ÖGGK, a non-profit health promotion society founded in 1893, offers its members a 10% discount on igevia allergy tests. This partnership provides igevia access to ÖGGK's member base and adds a tangible benefit to ÖGGK membership.
• Pharma-Time Verlag (PKA-Berufsausweis)minorGTM or Marketing Partner · 1 January 2019Through the PKA-Berufsausweis (pharmaceutical-kitchen assistant professional ID card issued by Pharma-Time Verlag), holders receive a 10% discount on igevia allergy tests. This targets pharmacy assistants as both potential buyers and distribution touchpoints.
• Macro Array Diagnostics (MADx)coreTechnology or Integration · 1 January 2018Igevia secured exclusive rights in 2018 for the 'out of home' use of the ALEX (Allergy Xplorer) multiplex IgE diagnostic chip developed by Macro Array Diagnostics. MADx's chip is the technological heart of the igevia test. Igevia co-developed the Allergy Explorer report software with MADx. The company has no direct competitor using this chip in the consumer/home-sampling format.
• Österreichische Post / Deutsche Post / DHLminorOthers · 1 January 2018Igevia cooperated closely with the Austrian Post and Deutsche Post/DHL to develop compliant postal packaging and logistics for the at-home blood sample return. The specially designed mailing envelope meets all regulatory requirements for the postal transport of blood samples. The company offers free return shipping to customers.
• Partner Laboratories (Wien and Germany)coreTechnology or Integration · 1 January 2018Blood samples collected by customers are analyzed in Igevia's partner laboratories located in Vienna and Germany. The lab receives only the anonymous sample ID — no personal customer data is shared with the laboratory. The partnership enables 10-14 day turnaround including postal transit. In early 2020, igevia expanded to work with one of Germany's largest laboratories for the Germany expansion.
• Prof. Dr. Karl-Christian Bergmann (Charité Berlin)minorStrategic or Co-development Partner · 1 January 2018Prof. Karl-Christian Bergmann, allergist and chairman of Stiftung Deutscher Polleninformationsdienst, collaborated with igevia to develop the Allergy Symptom Checker questionnaire included with the test kit. Prof. Bergmann actively advocates for the igevia test in media and professional publications as a superior alternative to prick testing.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• DayTwo: Gut-microbiome testing and personalized nutrition company offering consumer and clinical microbiome analysis — adjacent product category (gut health) with the same DNA-based stool testing model that Igevia's Darmfloratest employs.
• LetsGetChecked: Global DTC home diagnostic testing company offering self-collect test kits (sexual health, wellness, hormone, COVID) processed in partner labs with online results — closest direct analogue to Igevia's online-shop → kit → partner-lab → portal flow.
• YorkTest: UK-based food allergy and intolerance home testing company selling blood-spot IgG/IgE test kits direct to consumers with online results — directly comparable to Igevia's home allergy test model and a reference in UK/Ireland markets.
• Viome: US direct-to-consumer gut microbiome and wellness testing company selling at-home stool-based kits with personalized nutrition recommendations — directly comparable to Igevia's Gutflora product line and parallel DTC health-test consumer model.
• Everlywell: US-based direct-to-consumer home health testing platform offering multiple at-home test kits purchased online, mailed to a lab, with results delivered via online portal — the same DTC diagnostic flow Igevia uses for its allergy, metabolism, and gut-flora tests.
• Cell Science Systems (ALCAT / Allerflex): Specialty allergy and food intolerance testing laboratory offering comprehensive panels (ALCAT, Allerflex) direct to consumers and via practitioners — directly comparable to Igevia's broad-panel allergy testing focus.
• DNAfit / myDNA: Consumer DNA-based nutrition, fitness, and metabolism testing brands — parallel to Igevia's Stoffwechseltest product and broader personalized-health DTC positioning.

Broad incumbents

• Genova Diagnostics: Established US specialty clinical laboratory offering a broad portfolio of diagnostic testing (allergy, GI, hormonal, nutritional) via practitioner channels — parallels Igevia's HCP-channel B2B model but with a much larger test menu and incumbent reach.
• Thermo Fisher Scientific (ImmunoCAP): Global leader in vitro allergy diagnostics (ImmunoCAP platform) used by clinical labs and physicians worldwide — represents the dominant incumbent IgE testing standard against which Igevia positions its multiplex home-collect model.

Others

• Macro Array Diagnostics (MADx): Vienna-based developer of the ALEX / ALEX 3 multiplex IgE diagnostic chip that powers Igevia's core test — Igevia's exclusive technology partner for at-home use; MADx itself serves clinical labs globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCAB4Vbm3lb3R_BSSb4nMOuQ
• Facebookfacebook.com/igevia
• LinkedInlinkedin.com/company/igevia-gmbh
• Instagraminstagram.com/igevia_health

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Igevia